HealthQuill amyloid plaques
The US drug regulator has approved changes in the prescription of Eli Lilly’s drug Kisunla for treating adults with early Alzheimer’s disease, including those with mild memory problems or mild dementia.
Drugs Health Pharma

FDA permits slow dosing of Eli Lilly’s Alzheimer’s drug Kisunla

HQ Team July 9, 2025: The US drug regulator has approved changes in the prescription of Eli Lilly’s drug Kisunla for treating adults.

Read More
The US Food and Drug Administration has granted marketing access to Fujirebio Diagnostics, Inc.’s blood test to diagnose Alzheimer’s disease, the first such approval in the country.
Drugs Health Pharma

Simple blood test to detect Alzheimer’s disease gets US regulator’s nod

HQ Team May 18, 2025: The US Food and Drug Administration has granted marketing access to Fujirebio Diagnostics, Inc.’s blood test to diagnose.

Read More
Alzheimer's
Health Medical

Brain shrinkage from Alzheimer’s therapy is desirable, not harmful: Study

Bharti Jayshankar December 2, 2024: A recent study by University College London (UCL) has revealed that the decrease in brain volume observed in.

Read More